Delivery Order SPE2DR25D7064-SPE2DR26F2MRX
Award Date 12/10/25
Potential Completion Date 12/11/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,282.84 to AmerisourceBergen Drug Corp for the supply of Glycopyrrolate 1 mg/5 ml vials (5 ml units). This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by May 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,081.87 to AmerisourceBergen Drug Corp for the supply of Glycopyrrolate 1 mg/5 mL vials on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.93 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Glycopyrrolate 0.2 mg/mL vials. This firm fixed-price, non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $6,379.02 delivery order to AmerisourceBergen Drug Corp for Glycopyrrolate Inject, with an ultimate completion date of June 26, 2024. This non-set-aside, firm fixed price contract was competitively awarded on June 25, 2024, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical transaction within the company's broader federal medical...
- The Defense Logistics Agency awarded a $367,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.4 mg/2 ml vials of glycopyrrolate. The single award delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of the pharmaceutical to a facility in Conshohocken, Pennsylvania by July 31, 2023. As a major distributor of medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,706.37 delivery order for Glycopyrrolate 1 mg/5 ml vials on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, firm fixed-price contract represents a pharmaceutical supply delivery to support federal medical procurement needs. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565616879 - GLYCOPYRROLATE 0.2 MG/ML VIAL 5ML. The contract has an ultimate completion date of August 29, 2024 and a ceiling value of $15,536.46. The contract is not set aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty...
- This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.26, is for the supply of glycopyrrolate 0.2 mg/ml vials (20 ml) to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Glycopyrrolate 1 mg/5 ml vials, a medication used for various medical treatments. The contract has a ceiling value of $1,160.22 and runs through January 16, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,025.07 delivery order is for the supply of 4 mg/20 ml vials of the drug glycopyrrolate, a medication used to treat various conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of September 11, 2024. Amerisourcebergen, through its Corporate Office division, will provide these pharmaceutical products to support...